Results 221 to 230 of about 171,724 (348)
ABSTRACT Next‐generation incretin therapies, including semaglutide and tirzepatide, have transformed obesity and Type 2 diabetes management. However, evidence‐based nutritional strategies to support safe and effective use of these agents remain limited.
Marie Spreckley +2 more
wiley +1 more source
Euglena Attenuates High-Fat-Diet-Induced Obesity and Especially Glucose Intolerance. [PDF]
Ji T +8 more
europepmc +1 more source
ABSTRACT In a scenario with increasing cases of obesity and diabetes worldwide, branched‐chain amino acids (BCAA) metabolism has become an important factor in the understanding of these pathologies. More recently, its chronic high plasma levels have been postulated, alongside glucose, inflammatory factors, and other molecules, as an important ...
Bernardo Starling‐Soares +4 more
wiley +1 more source
The role of the glucagon-FGF21 axis in improving beta cell function during glucose intolerance and SGLT2 inhibition. [PDF]
Moreno-Lopez M +10 more
europepmc +1 more source
Fully Tunable Phosphorylation of RPS6A Ensures the Successful Development of Arabidopsis Seedlings
ABSTRACT Light enhances protein translation, enabling young seedlings to rapidly and timely acquire photosynthetic capacities. Sequential phosphorylation of ribosomal protein S6 (RPS6) was implicated in the light‐enhanced translation; however, the exact phosphorylation sites and the biological relevance of RPS6 multi‐phosphorylation in seedling ...
Yueh Cho +2 more
wiley +1 more source
This study evaluated the combined effects of antimicrobial photodynamic therapy (aPDT) and systemic resveratrol on bone repair around immediately placed implants in type 2 diabetic rats. Resveratrol improved glycemic control and body weight, while aPDT increased implant stability and bone mineralization.
Letícia Pitol‐Palin +8 more
wiley +1 more source
Association between glucose intolerance and fatty liver disease in women with previous gestational diabetes mellitus in urban Thailand: a prospective cohort study. [PDF]
Phaloprakarn C, Sethasine S.
europepmc +1 more source
Glucose intolerance in myotonic dystrophy type 1
Hiroto Takada +3 more
openalex +2 more sources

